JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$5.47B |
| 2 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.17B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$2.05B |
| 4 |
Amazon
AMZN
|
+$1.96B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.6B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$1.72B |
| 2 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$1.31B |
| 3 |
UnitedHealth
UNH
|
+$1.26B |
| 4 |
Automatic Data Processing
ADP
|
+$1.17B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$1.08B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.17% |
| 2 | Healthcare | 10.79% |
| 3 | Financials | 9.36% |
| 4 | Consumer Discretionary | 8.67% |
| 5 | Industrials | 7.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3326
Vanguard Emerging Markets Government Bond ETF
VWOB
$6.24B
| $2.2M | ﹤0.01% |
35,372
-6,438
| -15% | -$400K |
|
|
NGM
3327
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $2.2M | ﹤0.01% |
539,862
-26,677
| -5% | -$123K |
|
3328
FIGS
FIGS
$2.44B
| $2.19M | ﹤0.01% |
354,503
+223,740
| +171% | +$1.72M |
|
3329
Allegiant Air
ALGT
$2.34B
| $2.19M | ﹤0.01% |
23,767
+7,019
| +42% | +$631K |
|
3330
The GEO Group
GEO
$4.11B
| $2.18M | ﹤0.01% |
276,577
-31,780
| -10% | -$312K |
|
|
KRTX
3331
PUT
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $2.18M | ﹤0.01% |
+12,000
| New | +$2.3M |
|
3332
Varex Imaging
VREX
$779M
| $2.18M | ﹤0.01% |
119,688
-92,844
| -44% | -$1.77M |
|
3333
CALL
Vertex Pharmaceuticals
VRTX
$128B
| $2.17M | ﹤0.01% |
6,900
-48,200
| -87% | -$14.5M |
|
3334
PUT
PNC Financial Services
PNC
$103B
| $2.17M | ﹤0.01% |
17,100
-22,600
| -57% | -$3.41M |
|
|
HES
3335
PUT
DELISTED
Hess
HES
| $2.17M | ﹤0.01% |
16,400
-5,000
| -23% | -$696K |
|
3336
Adecoagro
AGRO
$1.29B
| $2.17M | ﹤0.01% |
267,884
+133,447
| +99% | +$1.07M |
|
3337
Matthews International
MATW
$725M
| $2.16M | ﹤0.01% |
59,955
+7,152
| +14% | +$263K |
|
3338
Ryan Specialty Holdings
RYAN
$10.7B
| $2.15M | ﹤0.01% |
53,438
+7,470
| +16% | +$307K |
|
3339
The Joint Corp
JYNT
$120M
| $2.15M | ﹤0.01% |
127,471
-1,249
| -1% | -$20.7K |
|
|
ACB
3340
Aurora Cannabis
ACB
$233M
| $2.14M | ﹤0.01% |
24,800
-17,959
| -42% | -$157K |
|
3341
AMC Entertainment Holdings
AMC
$2.23B
| $2.14M | ﹤0.01% |
42,719
+17,295
| +68% | +$916K |
|
3342
Vanguard S&P Small-Cap 600 ETF
VIOO
$4.37B
| $2.14M | ﹤0.01% |
24,081
+21,253
| +752% | +$1.95M |
|
3343
Globalstar
GSAT
$10.7B
| $2.13M | ﹤0.01% |
122,699
+39,554
| +48% | +$729K |
|
3344
CALL
Innoviz Technologies
INVZ
$107M
| $2.13M | ﹤0.01% |
610,000
+100,000
| +20% | +$443K |
|
3345
Tootsie Roll Industries
TR
$3.08B
| $2.13M | ﹤0.01% |
51,842
+9,588
| +23% | +$382K |
|
3346
Scholastic
SCHL
$781M
| $2.12M | ﹤0.01% |
62,018
+13,732
| +28% | +$585K |
|
3347
CALL
Bilibili
BILI
$7.3B
| $2.12M | ﹤0.01% |
+90,000
| New | +$2.14M |
|
|
JNCE
3348
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $2.1M | ﹤0.01% |
1,136,847
+886,639
| +354% | +$1.1M |
|
3349
Tecnoglass Holdings
TGLS
$1.86B
| $2.1M | ﹤0.01% |
50,094
+514
| +1% | +$18.4K |
|
3350
CareDx
CDNA
$2.34B
| $2.09M | ﹤0.01% |
229,152
-113,031
| -33% | -$1.45M |
|
Similar funds
JP Morgan Chase's Q1 2023 Portfolio in Review
As of Q1 2023, JP Morgan Chase held 7,579 positions worth $821B, up 8.2% from $759B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q1 2023 filing shows 752 new, 3,314 increased, 2,056 reduced and 652 closed positions. Its largest new stake was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M. The largest sale was Eli Lilly, an estimated $1.72B.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.
- JP Morgan Chase's largest Q1 2023 buy was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q1 2023, an estimated $5.47B increase.
- JP Morgan Chase's biggest Q1 2023 reduction was Eli Lilly, cutting an estimated $1.72B.
- JP Morgan Chase fully exited IAA, Inc. Common Stock in Q1 2023, selling an estimated $155M.
- JP Morgan Chase's ten largest holdings make up 17% of its $821B portfolio in Q1 2023.
- JP Morgan Chase opened 752 new positions and closed 652 in Q1 2023.
- JP Morgan Chase's portfolio value rose 8.2% quarter-over-quarter to $821B.
Based on JP Morgan Chase's 13F filing for Q1 2023, filed 11 May 2023.